Health Insurance Innovations (HIIQ) Issues FY18 Earnings Guidance

Health Insurance Innovations (NASDAQ:HIIQ) updated its FY18 earnings guidance on Wednesday. The company provided EPS guidance of $2.47-2.57 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.49. The company issued revenue guidance of $293-303 million, compared to the consensus revenue estimate of $294.67 million.

A number of research firms have recently weighed in on HIIQ. Canaccord Genuity reaffirmed a buy rating and issued a $62.00 price target (up from $55.00) on shares of Health Insurance Innovations in a research note on Thursday. ValuEngine raised shares of Health Insurance Innovations from a hold rating to a buy rating in a research note on Thursday. BidaskClub raised shares of Health Insurance Innovations from a buy rating to a strong-buy rating in a research note on Tuesday, June 5th. Zacks Investment Research raised shares of Health Insurance Innovations from a sell rating to a hold rating in a research note on Tuesday, June 5th. Finally, Cantor Fitzgerald reaffirmed a buy rating and issued a $60.00 price target on shares of Health Insurance Innovations in a research note on Monday. Ten investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of Buy and a consensus price target of $44.51.

Health Insurance Innovations stock traded up $6.10 during mid-day trading on Thursday, hitting $44.15. 1,167,600 shares of the company’s stock were exchanged, compared to its average volume of 372,203. The company has a market capitalization of $557.14 million, a price-to-earnings ratio of 36.79 and a beta of 0.47. Health Insurance Innovations has a 1-year low of $12.65 and a 1-year high of $44.40.

Health Insurance Innovations (NASDAQ:HIIQ) last posted its earnings results on Wednesday, August 1st. The financial services provider reported $0.61 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.58 by $0.03. The firm had revenue of $71.70 million for the quarter, compared to the consensus estimate of $70.51 million. Health Insurance Innovations had a net margin of 6.17% and a return on equity of 20.15%. The business’s quarterly revenue was up 16.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.46 earnings per share. equities research analysts forecast that Health Insurance Innovations will post 2.09 EPS for the current year.

In other Health Insurance Innovations news, Director Anthony Barkett bought 3,597 shares of the stock in a transaction on Tuesday, May 8th. The shares were purchased at an average cost of $27.65 per share, with a total value of $99,457.05. Following the completion of the transaction, the director now directly owns 52,944 shares of the company’s stock, valued at approximately $1,463,901.60. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director John Fichthorn sold 18,414 shares of the stock in a transaction on Friday, June 15th. The stock was sold at an average price of $34.98, for a total transaction of $644,121.72. Following the transaction, the director now directly owns 7,608 shares in the company, valued at $266,127.84. The disclosure for this sale can be found here. Insiders have acquired 19,759 shares of company stock worth $611,607 over the last three months. Company insiders own 55.94% of the company’s stock.

Health Insurance Innovations Company Profile

Health Insurance Innovations, Inc operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provides three months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits; and supplemental insurance products, including pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies.

See Also: Leveraged Buyout (LBO)

Earnings History and Estimates for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply